ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 1,048,722 Value ($000) $16,154 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 1,085,013 Value ($000) $22,213 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 882,753 Value ($000) $17,711 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 819,173 Value ($000) $16,125 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 762,718 Value ($000) $17,165 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 750,208 Value ($000) $19,164 Avg Close $23.16 Range $20.63 - $27.67

Q2 2024

Shares 682,395 Value ($000) $15,950 Avg Close $21.05 Range $15.96 - $26.00

Q1 2024

Shares 475,456 Value ($000) $8,364 Avg Close $15.34 Range $10.90 - $19.50

Q4 2023

Shares 464,657 Value ($000) $6,431 Avg Close $12.23 Range $9.80 - $15.41

Q3 2023

Shares 432,972 Value ($000) $5,915 Avg Close $16.84 Range $12.38 - $20.77

Q2 2023

Shares 414,444 Value ($000) $8,459 Avg Close $20.21 Range $17.15 - $23.98

Q1 2023

Shares 35,388 Value ($000) $775 Avg Close $20.34 Range $14.56 - $25.34

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	1,048,722	$16,154	$19.92	$15.14 - $24.64
Q3 2025	1,085,013	$22,213	$20.16	$17.43 - $24.38
Q2 2025	882,753	$17,711	$18.93	$13.30 - $24.11
Q1 2025	819,173	$16,125	$21.52	$18.67 - $25.37
Q4 2024	762,718	$17,165	$25.92	$21.43 - $30.03
Q3 2024	750,208	$19,164	$23.16	$20.63 - $27.67
Q2 2024	682,395	$15,950	$21.05	$15.96 - $26.00
Q1 2024	475,456	$8,364	$15.34	$10.90 - $19.50
Q4 2023	464,657	$6,431	$12.23	$9.80 - $15.41
Q3 2023	432,972	$5,915	$16.84	$12.38 - $20.77
Q2 2023	414,444	$8,459	$20.21	$17.15 - $23.98
Q1 2023	35,388	$775	$20.34	$14.56 - $25.34